Gleiss Lutz advises Paracelsus-Kliniken on the merger of Paracelsus-Klinik Hemer with DGD’s Hemer Lung Hospital
A Gleiss Lutz team has advised Paracelsus-Kliniken Deutschland on the merger of Paracelsus-Klinik Hemer with Hemer Lung Hospital, which belongs to Deutsche Gemeinschafts-Diakonieverband (DGD), an association of church-based healthcare providers. After the merger, the range of medical services on offer will be expanded, existing structures modernised, and the resulting entity given a new focus. The closing of the transaction is subject to customary antitrust and regulatory clearances.
Paracelsus-Kliniken belongs to Porterhouse Group AG. With around 37 facilities at 19 locations in all, it is one of Germany’s largest hospital owners. Nationwide, around 4,600 employees treat almost 73,000 inpatients per year. The company generates a turnover of some EUR 400 million per year. Its registered office is in Osnabrück.
Porterhouse is an international, family-run holding company with registered office in Lucerne. The company was founded in 2016 and employs over 6,000 staff worldwide. In 2018, Gleiss Lutz advised Porterhouse on its acquisition of the Paracelsus-Kliniken Group, providing regular advice since then on a number of matters. These have included the sale of Paracelsus-Klinik Zwickau, a comprehensive restructuring of the group, as well as the refinancing of clinics and a strategic partnership with Niels-Stensen-Kliniken.
The following team of Gleiss Lutz lawyers advised Paracelsus on the transaction: Dr. Patrick Kaffiné (partner, lead), Dr. Maximilian Hirsch (both Frankfurt), Dr. Martin Viciano Gofferje (partner, Berlin, all M&A), Dr. Stefan Mayer (partner), Dr. Ocka Stumm (partner), Dr. Dominik Monz (all Tax), Dr. Birgit Colbus (counsel, Competition/Antitrust, all Frankfurt), Dr. Lisa Kappler (Public Law, Stuttgart).